Miriam Merad, MD, PhD, Receives Top Award for Contributions to Cancer Immunology and Immunotherapy
Past Awardees Include Nobel Laureates
Miriam Merad, MD, PhD, Director of the Precision Immunotherapy Institute and the program leader of the Cancer Immunology and Immunotherapy Group at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, has received the Cancer Research Institute’s top honor, one previously awarded to two Nobel laureates, for her contributions to cancer immunology and immunotherapy.
Dr. Merad received the 2018 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology—including a $5,000 prize and a gold medallion bearing the likeness of Dr. Coley—at the Cancer Research Institute’s annual gala on Thursday, October 25, at The Metropolitan Club in New York City. The award was established in 1975 in honor of William B. Coley, MD, a pioneer of cancer immunotherapy, whose daughter, Helen Coley Nauts, founded the Cancer Research Institute 65 years ago.
Dr. Merad, who is also Director of Mount Sinai’s Human Immune Monitoring Center, earned the honor for her contributions to understanding the biology of macrophages and dendritic cells, which are important immune cells that orchestrate adaptive responses against cancer. Among her contributions are discoveries that revealed the embryonic origin of macrophages as well as the local factors that maintain their distinct populations within tissues. She has also provided groundbreaking insights into the mechanisms that control the development, stability, and function of macrophages and dendritic cells, including defining their roles in the context of immunotherapy and tumor development.
“Every year, the Cancer Research Institute recognizes outstanding achievements in immunology by bestowing the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology,” the Cancer Research Institute, a nonprofit organization dedicated to the discovery and development of immunotherapies for all forms of cancer, said to Dr. Merad in an award letter. “The Award recognizes your important contributions to the biology of myeloid immune cells. In particular, your discoveries that revealed the embryonic origin of macrophages as well as the local factors that maintain their distinct populations within tissues, and your groundbreaking insights into the mechanisms that control the development, homeostasis, and function of macrophages and dendritic cells will be celebrated.”
Past recipients of the William B. Coley Award have included James Allison, PhD, in 2005 and Tasuku Honjo, MD, PhD, in 2014. Drs. Allison and Honjo, who pioneered treatments that unleash the body’s own immune system to attack cancer cells, received the Nobel Prize in Physiology or Medicine on October 1, 2018.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.